|Mr. David Richard Hainsworth||CEO & Exec. Chairman||40k||N/A||1973|
|Mr. Daya Uka||Chief Financial Officer||153.08k||N/A||N/A|
|Dr. Belinda Di Bartolo||Chief Operations Officer||182.33k||N/A||N/A|
|Dr. Carolyn M. Sue A.M., B.S., Ph.D.||Member of Medical Advisory Board & Chief Medical Officer of NTCELL||50k||N/A||1963|
|Mr. Madhukar Bhalla FCIS||Company Sec.||40k||N/A||1959|
|Dr. James A. Mckenna||Chief Scientific Officer||N/A||N/A||N/A|
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.
Living Cell Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.